Core Scientific, Inc.
CORZ
$16.42
-$0.55-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -288.62M | -891.18M | -1.20B | -1.07B | -1.44B |
| Total Depreciation and Amortization | 80.18M | 92.22M | 102.79M | 112.76M | 120.12M |
| Total Amortization of Deferred Charges | 5.99M | 6.07M | 6.00M | 4.83M | 3.76M |
| Total Other Non-Cash Items | -43.84M | 572.06M | 964.36M | 922.09M | 1.38B |
| Change in Net Operating Assets | 524.53M | 359.81M | 139.55M | 8.32M | -27.64M |
| Cash from Operations | 278.25M | 138.99M | 12.92M | -19.88M | 42.90M |
| Capital Expenditure | -729.00M | -482.95M | -269.63M | -151.49M | -94.96M |
| Sale of Property, Plant, and Equipment | 3.46M | 1.93M | 1.67M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.21M | -15.20M | -5.14M | -5.19M | -231.00K |
| Cash from Investing | -740.75M | -496.22M | -273.10M | -156.68M | -95.19M |
| Total Debt Issued | -- | 610.16M | 1.06B | 1.06B | 1.06B |
| Total Debt Repaid | -37.80M | -50.79M | -314.64M | -298.07M | -310.86M |
| Issuance of Common Stock | 6.91M | 4.72M | 5.15M | 5.15M | 59.89M |
| Repurchase of Common Stock | -32.22M | -5.89M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.32M | -3.85M | -3.85M | 12.77M |
| Cash from Financing | -63.10M | 556.88M | 744.43M | 761.01M | 819.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -525.60M | 199.64M | 484.24M | 584.45M | 767.27M |